RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Renalytix plc
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)
Close on Oct 19, 2026
- Market cap
- $375.75M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Renalytix's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Icahn School Of Medicine At Mount Sinai (“ismms”) | 35,653,477 | 10.68% | 13D (active) amendment | Nov 1, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Mount Sinai Health System, Inc. | 10% owner | 9,956,874 | Nov 5, 2024 |
| School Of Medicine At Mount Sinai Icahn | 10% owner | 19,317,248 | Nov 5, 2024 |
| Mount Sinai Hospitals Group, Inc. | 10% owner | 32,683,998 | Nov 5, 2024 |
| Sinai Hospital Mount | 10% owner | – | Nov 5, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Mount Sinai Hospitals Group, Inc. 10% owner | Nov 1, 2024 | Other | +13,366,750 | $0.12 | $1.60M | 32,683,998 |
| School Of Medicine At Mount Sinai Icahn 10% owner | Apr 24, 2024 | Other | +9,360,374 | $0.25 | $2.34M | 19,317,248 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.